Logo image of NIM

NUVEEN SELECT MATURIT MUNI (NIM) Stock Overview

USA - NYSE:NIM - US67061T1016

9.3 USD
-0.02 (-0.21%)
Last: 9/18/2025, 8:08:56 PM
Fundamental Rating

3

Taking everything into account, NIM scores 3 out of 10 in our fundamental rating. NIM was compared to 0 industry peers in the Unkown industry. While NIM has a great health rating, there are worries on its profitability. NIM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year NIM was profitable.
NIM had positive earnings in 4 of the past 5 years.
NIM had a negative operating cash flow in each of the past 5 years.
NIM Yearly Net Income VS EBIT VS OCF VS FCFNIM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M 8M

1.2 Ratios

Industry RankSector Rank
ROA 2.67%
ROE 2.69%
ROIC 2.42%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NIM Yearly ROA, ROE, ROICNIM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 2 -2 4 6

1.3 Margins

In the last couple of years the Profit Margin of NIM has declined.
In the last couple of years the Operating Margin of NIM has remained more or less at the same level.
NIM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 84.12%
PM (TTM) 73.99%
GM 85.76%
OM growth 3Y1.11%
OM growth 5Y0.25%
PM growth 3YN/A
PM growth 5Y-5.58%
GM growth 3Y1.04%
GM growth 5Y0.26%
NIM Yearly Profit, Operating, Gross MarginsNIM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 100 150 200

7

2. Health

2.1 Basic Checks

NIM has less shares outstanding than it did 5 years ago.
NIM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NIM Yearly Shares OutstandingNIM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2025 2M 4M 6M 8M 10M
NIM Yearly Total Debt VS Total AssetsNIM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2025 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 82.84 indicates that NIM is not in any danger for bankruptcy at the moment.
There is no outstanding debt for NIM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 82.84
ROIC/WACCN/A
WACCN/A
NIM Yearly LT Debt VS Equity VS FCFNIM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2025 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 3.13 indicates that NIM has no problem at all paying its short term obligations.
A Quick Ratio of 3.13 indicates that NIM has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 3.13
NIM Yearly Current Assets VS Current LiabilitesNIM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2025 500K 1M 1.5M 2M 2.5M

1

3. Growth

3.1 Past

The earnings per share for NIM have decreased strongly by -57.14% in the last year.
The Earnings Per Share has been decreasing by -4.70% on average over the past years.
The Revenue has been growing slightly by 5.69% in the past year.
The Revenue has been growing slightly by 0.97% on average over the past years.
EPS 1Y (TTM)-57.14%
EPS 3YN/A
EPS 5Y-4.7%
EPS Q2Q%47.38%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y5.11%
Revenue growth 5Y0.97%
Sales Q2Q%11.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NIM Yearly Revenue VS EstimatesNIM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M

0

4. Valuation

4.1 Price/Earnings Ratio

NIM is valuated quite expensively with a Price/Earnings ratio of 35.77.
The average S&P500 Price/Earnings ratio is at 27.41. NIM is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 35.77
Fwd PE N/A
NIM Price Earnings VS Forward Price EarningsNIM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NIM Per share dataNIM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

NIM has a Yearly Dividend Yield of 3.63%.
NIM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.63%

5.2 History

NIM has paid a dividend for at least 10 years, which is a reliable track record.
NIM has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
NIM Yearly Dividends per shareNIM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NIM Yearly Income VS Free CF VS DividendNIM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M 8M

NUVEEN SELECT MATURIT MUNI

NYSE:NIM (9/18/2025, 8:08:56 PM)

9.3

-0.02 (-0.21%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)06-02 2025-06-02
Earnings (Next)12-02 2025-12-02
Inst Owners40.12%
Inst Owner Change13.58%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap115.79M
Analysts0
Price TargetN/A
Short Float %0.12%
Short Ratio0.73
Dividend
Industry RankSector Rank
Dividend Yield 3.63%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years2
Div Non Decr Years2
Ex-Date08-15 2025-08-15 (0.0275)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 35.77
Fwd PE N/A
P/S 26.08
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)0.26
EY2.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.36
BVpS9.81
TBVpS9.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.67%
ROE 2.69%
ROCE 3.06%
ROIC 2.42%
ROICexc 2.42%
ROICexgc 2.42%
OM 84.12%
PM (TTM) 73.99%
GM 85.76%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y7.79%
ROICexcg growth 5Y2.44%
ROICexc growth 3Y7.79%
ROICexc growth 5Y2.44%
OM growth 3Y1.11%
OM growth 5Y0.25%
PM growth 3YN/A
PM growth 5Y-5.58%
GM growth 3Y1.04%
GM growth 5Y0.26%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.13
Quick Ratio 3.13
Altman-Z 82.84
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.14%
EPS 3YN/A
EPS 5Y-4.7%
EPS Q2Q%47.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.69%
Revenue growth 3Y5.11%
Revenue growth 5Y0.97%
Sales Q2Q%11.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.23%
EBIT growth 3Y6.28%
EBIT growth 5Y1.22%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A